Ocular Therapeutix

About:

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

Website: http://www.ocutx.com

Twitter/X: ocutx

Top Investors: Perceptive Advisors, Baxter International, Polaris Partners, Deep Track Capital, Versant Ventures

Description:

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

Total Funding Amount:

$712M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Bedford, Massachusetts, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)ocutx.com

Founders:

Amarpreet Sawhney, Farhad Khosravi

Number of Employees:

251-500

Last Funding Date:

2024-02-22

IPO Status:

Public

© 2025 bioDAO.ai